TerminatedNCT04231643

Effects of Cannabis on Cognition and Endocannabinoid Levels in Bipolarity Patients and Healthy Volunteers

Medication studyAges 18–50United States

The study in practice

Understand this study

Listed age limits: 18 years to 50 years.

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Study start dateStarted: September 1, 2021

Recruitment status: Terminated
Enrollment listed in the registry: 19
Sponsor: University of California, San Diego
Sponsor type: University
Study type: Drug
Intervention type: Medication / drug
Study phase: Early Phase 1
Locations: United States
Age range: From 18 Years to 50 Years
Official registry ID: NCT04231643
Official title: Show the full official title
A Randomized, Controlled Trial of Cannabis in Bipolar Disorder Patients and Healthy Volunteers Evaluating Cognition and Endocannabinoid Levels

Terminated

San Diego

FAQ

Who is behind this study?

The study sponsor is University of California, San Diego, a university.

Does this study involve medication?

Yes. The study involves medication, including Dronabinol, Epidiolex and Placebos.

Who can participate?

Listed age limits: 18 years to 50 years.

Is this study still recruiting?

The registry lists this study as terminated.